Generic Drug Makers Facing Squeeze on Revenue

Tuesday, December 4, 2012 - 04:20 in Mathematics & Economics

More than 40 brand-name drugs lost patents this year, but generic drug makers have been scrambling to make up revenue next year when far fewer patents expire.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net